B

Bajaj Healthcare

(NSE: BAJAJHCARE)

BAJAJHCARE

353.5

0.00 (0.00%)

Bajaj Healthcare Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Bajaj Healthcare Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Bajaj Healthcare Price Summary

Today High

354.95

Today Low

349

52 Week High

354.95

52 Week Low

349

Bajaj Healthcare Fundamentals

Market Cap

939.3 Cr

CASA

0.0

No. Of Shares

2.8 Cr

P/E

7.8

P/B

2.5

Face Value

5.0

Dividend Yeild

0.6

Book Value

187.3

Net Interest Income

16.69 L

Cost to Income

NA

Promoter Holdings

67.3

EPS

60.23 L

CAR

NA

ROE

38.1

ROCE

35.9

Profit Growth

NA

Bajaj Healthcare Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Bajaj Healthcare

353.5

939.3 Cr

2.5

7.8

60.23 L

38.1

35.9

16.69 L

RPG Life Sciences

786.75

881.6 Cr

3.0

16.0

24.19 L

20.4

27.2

32.00 L

Medicamen Biotech

1006.65

873.6 Cr

5.1

52.2

10.2

10.1

13.1

15.33 L

Bliss GVS Pharma

76.55

820.1 Cr

1.4

15.1

6.54 L

9.4

11.8

11.0 Cr

Themis Medicare

1011.7

816.9 Cr

1.4

9.7

28.97 L

15.5

17.0

41.21 L

Jagson Pal Pharma

361.05

813.8 Cr

1.8

12.2

6.51 L

15.7

19.4

3.0 Cr

FAQ’s on Bajaj Healthcare

About Bajaj Healthcare

The company was incorporated as Bajaj Healthcare Private Limited on July 15, 1993 under the Companies Act, 1956, with the Registrar of Companies, Mumbai bearing Registration Number - 072892. The status of the company was changed to a public limited company and the name of the company was changed to Bajaj Healthcare Limited by a special resolution passed on March 15, 2005. A fresh certificate of incorporation consequent to the change of name was granted to the company on March 31, 2005, by the Registrar of Companies, Mumbai. The company began its operations in the year 1993 with an API manufacturing unit in Tarapur, near Mumbai. Over the years it has expanded its scale and scope of operations and currently it operates five manufacturing units for manufacture of APIs, Intermediates and Formulations.

The company’s present product portfolio consists of various APIs in the therapeutic categories of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal & Bacteriostatic, Diuretic & Vasodilator, Mineral & Nutritional supplements, Bronchodilater / Anti-asthmatic and Nootropics. The company’s Formulations unit manufactures tablets, capsules and sachets for its own brands as well as under Loan License (job work) for other pharmaceutical companies. Currently, the company manufactures formulations for GlaxoSmithKline Pharmaceuticals (GSK) and USV (USV) on a Loan License basis. The formulations manufactured for its own brands are manufactured and marketed under a separate division of Bajaj Medicare and it also has marketing tie-up with TTK Healthcare. The FDFs manufactured by it covers various therapeutic segments like Antibiotics, Anti-Arrhythmia, Anti-Convulsants, Anti-Diabetes, Anti-Platelets, NSAIDs, Vitamins & its Derivatives, Anti-Hypertensive, Anti-Bacterial, Anti-Malarial, Cholinesterase Inhibitors, etc.

With the combined production of its API facilities and that of its Formulation unit, the company’s product portfolio consists of APIs and FDFs which shall be marketed in domestic and international markets as branded generics. Presently it is supplying its APIs and FDFs both domestically and exporting to various countries in regions like, Europe, USA, Australia, Africa, South America, etc. With its long standing operations and quality products, the company has built a strong relationship with its customers for both APIs and FDFs. Some of its major clients include nationally and internationally known pharmaceutical companies like Glaxo Smithkline Consumer Healthcare, Ava Inc., Abbott Healthcare, Piramal Enterprises, Pfizer, Colgate Palmolive India, Lupin and Intas Pharmaceuticals to name a few.

Business area of the company

Bajaj Healthcare is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) caters to various therapeutic segments.

Major events

  • 1993-1994: Incorporated under Companies Act, 1956 as Bajaj Healthcare Private Limited by setting up plant at Tarapur.
  • 1996-1997: First Export Sale.
  • 2004-2005: Changed the status of the company from Private to Public i.e. to Bajaj Healthcare Limited.
  • 2005-2006: Purchase and Set-up a new facility at Salvi, Vadodara.
  • 2005-2006: Set up Corporate Office in Masjid Bunder.
  • 2006-2007: Purchase addition Plot N- 128 at Tarapur.
  • 2006-2007: Issued 20,00,000, Non- Cumulative Preference Shares of Rs 10 each.
  • 2006-2007: Major Term loan of Rs 863.00 lakhs was sanction and its total indebtedness reached to Rs 2,265 Lakh.
  • 2007-2008 Purchase and Set-up a new facility at Manjusar, Vadodara.
  • 2007-2008 Increase in Capacity of its major products like; 100% Vitamin C and its derivatives and 50% in Choline Bitartrate, etc.
  • 2009-2010: Launched own brands under Manjusar/ Medicare.
  • 2013-2014: Purchase and Set-up a new facility at Panoli, Ankleshwar.
  • 2013-2014: First GVK Agreement.
  • 2013-2014: First USV Agreement.
  • 2014-2015: Purchase and Set-up a Second facility at Tarapur, Maharashtra.
  • 2015-2016: Acquisition of premises for new Corporate Office in Thane and set-up of the same.

Trade Bajaj Healthcare today

Create a free portfolio in Trinkerr and earn and grow along with peers